Cell therapy demand is outpacing manufacturing capacity, forcing clinical supply teams to rethink patient scheduling, production slots, and real-time coordination.
- How Real-World, Real-Time, And Synthetic Data Are Revolutionizing Clinical Trial Supply Chains
- The Atlantic Divide: Forcing FDA Demographics Onto European Supply Chains
- Expanding Clinical Trials In Africa Without Disruption
- Bridging Clinical Operations And Supply Chain: Aligning Execution In High-Stakes Trials
- At The Point Of Review: How Clinical Shipments Are Evaluated In Practice
- The cGMP Reality Of Clinical Supply For Advanced Therapies
- How Exit Strategy Should Shape Clinical Trial Supply Planning
- This Assumption Will Break Your Clinical Trial
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Gain Confidence In Clinical Trial Outcomes
Delve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.
-
Five Key Trends In CMC
CMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.
-
Prepping For Commercialization Through Supply Chain Logistics
While cell and gene therapies are bringing new hope to patients experiencing rare and serious diseases, uncover how they're disrupting the biopharma market in new and challenging ways.
-
Advantages Of Robotic Aseptic Processing
Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
IRT: A New Approach To Meeting The Needs Of Early Phase Trials
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
Enhancing Clinical IP Efficiency & Compliance
A U.S.-based clinical research sponsor optimized their supply chain visibility, reduced costs and risks, and improved efficiency by replacing their manual inventory management system.
-
Avoiding The Risk Of A Non-Transparent Clinical Supply Solution
With the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.
-
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs
When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
Overcome The Supply Chain Complexities Of Vaccine Development
Explore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
-
Navigate Complex Ancillary Supply Sourcing Challenges
Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.